Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk

Completed · Phase 4

Conditions studied: HIV, Contraception

In brief

This is a prospective cohort study focusing on HIV negative women. The investigators want to learn how the contraceptive methods of depot medroxyprogesterone acetate (DMPA), etonogestrel implant (Eng-Implant), levonorgestrel intrauterine device (Lng-IUD) and the ParaGard® T 380A Intrauterine Copper Contraceptive impact the vaginal immune environment.

Key facts

Study ID
NCT02357368
Run by
Lisa Haddad
People needed
59
Starts
2015-02-01
Expected to finish
2019-10-23
Last updated by the study team
2020-11-18

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.